On the Potential of Preemptive Genotyping Towards Preventing Medication-Related Adverse Events: Results from the South Korean National Health Insurance Database Jonathan S. SchildcroutJoshua C. DennyDan M. Roden Commentary 21 November 2016 Pages: 1 - 2
The Harms of Antipsychotic Drugs: Evidence from Key Studies Thomas J. MooreCurt D. Furberg Current Opinion 19 November 2016 Pages: 3 - 14
Pharmaceutical Benefit–Risk Communication Tools: A Review of the Literature Dominic WayHortense BlazsinFrederic Bouder Review Article 14 October 2016 Pages: 15 - 36
Evaluating the Safety Profile of Non-Active Implantable Medical Devices Compared with Medicines Josep PanePreciosa M. ColomaIrene Rebollo Review Article Open access 07 December 2016 Pages: 37 - 47
Vancomycin-Induced Thrombocytopenia: A Narrative Review Mehdi MohammadiZahra Jahangard-RafsanjaniMaryam Taghizadeh-Ghehi Review Article 15 November 2016 Pages: 49 - 59
Proton Pump Inhibitors and Risk of Rhabdomyolysis Scott J. DuncanColin W. Howden Review Article 12 November 2016 Pages: 61 - 64
Role of Preemptive Genotyping in Preventing Serious Adverse Drug Events in South Korean Patients Grace Juyun KimSoo Youn LeeJu Han Kim Original Research Article 15 September 2016 Pages: 65 - 80
Current Safety Concerns with Human Papillomavirus Vaccine: A Cluster Analysis of Reports in VigiBase® Rebecca E. ChandlerKristina JuhlinG. Niklas Norén Original Research Article Open access 16 September 2016 Pages: 81 - 90
The Role of Hemoglobin Laboratory Test Results for the Detection of Upper Gastrointestinal Bleeding Outcomes Resulting from the Use of Medications in Observational Studies Elisabetta PatornoJoshua J. GagneMarsha A. Raebel Original Research Article 15 November 2016 Pages: 91 - 100